BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: May C, Nordhoff E, Casjens S, Turewicz M, Eisenacher M, Gold R, Brüning T, Pesch B, Stephan C, Woitalla D, Penke B, Janáky T, Virók D, Siklós L, Engelhardt JI, Meyer HE. Highly immunoreactive IgG antibodies directed against a set of twenty human proteins in the sera of patients with amyotrophic lateral sclerosis identified by protein array. PLoS One 2014;9:e89596. [PMID: 24586901 DOI: 10.1371/journal.pone.0089596] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Malaspina A, Puentes F, Amor S. Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective. International Immunology 2015;27:117-29. [DOI: 10.1093/intimm/dxu099] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 7.4] [Reference Citation Analysis]
2 Lall D, Baloh RH. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia. J Clin Invest 2017;127:3250-8. [PMID: 28737506 DOI: 10.1172/JCI90607] [Cited by in Crossref: 80] [Cited by in F6Publishing: 50] [Article Influence: 16.0] [Reference Citation Analysis]
3 De Marchi F, Munitic I, Amedei A, Berry JD, Feldman EL, Aronica E, Nardo G, Van Weehaeghe D, Niccolai E, Prtenjaca N, Sakowski SA, Bendotti C, Mazzini L. Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact. Neurosci Biobehav Rev 2021;127:958-78. [PMID: 34153344 DOI: 10.1016/j.neubiorev.2021.06.027] [Reference Citation Analysis]
4 Angelini DF, De Angelis F, Vacca V, Piras E, Parisi C, Nutini M, Spalloni A, Pagano F, Longone P, Battistini L, Pavone F, Marinelli S. Very Early Involvement of Innate Immunity in Peripheral Nerve Degeneration in SOD1-G93A Mice. Front Immunol 2020;11:575792. [PMID: 33329541 DOI: 10.3389/fimmu.2020.575792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Prüss H. Autoantibodies in neurological disease. Nat Rev Immunol 2021. [PMID: 33976421 DOI: 10.1038/s41577-021-00543-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
6 Schrötter A, Magraoui FE, Marcus K, Park YM, Meyer HE, Grinberg LT. New milestones in the development of characterization tools for neurodegenerative diseases in proteomics: 22nd HUPO BPP Workshop 7 October 2014, Madrid, Spain. Proteomics 2015;15:627-9. [PMID: 25676247 DOI: 10.1002/pmic.201570035] [Reference Citation Analysis]
7 Meszlényi V, Patai R, Polgár TF, Nógrádi B, Körmöczy L, Kristóf R, Spisák K, Tripolszki K, Széll M, Obál I, Engelhardt JI, Siklós L. Passive Transfer of Sera from ALS Patients with Identified Mutations Evokes an Increased Synaptic Vesicle Number and Elevation of Calcium Levels in Motor Axon Terminals, Similar to Sera from Sporadic Patients. Int J Mol Sci 2020;21:E5566. [PMID: 32756522 DOI: 10.3390/ijms21155566] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Polgár TF, Meszlényi V, Nógrádi B, Körmöczy L, Spisák K, Tripolszki K, Széll M, Obál I, Engelhardt JI, Siklós L, Patai R. Passive Transfer of Blood Sera from ALS Patients with Identified Mutations Results in Elevated Motoneuronal Calcium Level and Loss of Motor Neurons in the Spinal Cord of Mice. Int J Mol Sci 2021;22:9994. [PMID: 34576165 DOI: 10.3390/ijms22189994] [Reference Citation Analysis]
9 Demarshall C, Sarkar A, Nagele EP, Goldwaser E, Godsey G, Acharya NK, Nagele RG. Utility of Autoantibodies as Biomarkers for Diagnosis and Staging of Neurodegenerative Diseases. Omic Studies of Neurodegenerative Disease: Part B. Elsevier; 2015. pp. 1-51. [DOI: 10.1016/bs.irn.2015.05.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
10 Chen X, Shen X, Zhang X, Zhan Y, Fang F. Polygenic associations and causal inferences between serum immunoglobulins and amyotrophic lateral sclerosis. Clin Chim Acta 2021;521:131-6. [PMID: 34245689 DOI: 10.1016/j.cca.2021.07.007] [Reference Citation Analysis]
11 Cheng Y, Chen Y, Shang H. Aberrations of biochemical indicators in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Transl Neurodegener 2021;10:3. [PMID: 33419478 DOI: 10.1186/s40035-020-00228-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Obál I, Klausz G, Mándi Y, Deli M, Siklós L, Engelhardt JI. Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-α, IL-6, and IL-10 in the spinal cord and serum of mice. J Neuroinflammation 2016;13:121. [PMID: 27220674 DOI: 10.1186/s12974-016-0586-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
13 Häggmark A, Schwenk JM, Nilsson P. Neuroproteomic profiling of human body fluids. Proteomics Clin Appl 2016;10:485-502. [PMID: 26286680 DOI: 10.1002/prca.201500065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
14 Duarte JG, Blackburn JM. Advances in the development of human protein microarrays. Expert Rev Proteomics 2017;14:627-41. [PMID: 28644690 DOI: 10.1080/14789450.2017.1347042] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 9.8] [Reference Citation Analysis]
15 Obál I, Nógrádi B, Meszlényi V, Patai R, Ricken G, Kovacs GG, Tripolszki K, Széll M, Siklós L, Engelhardt JI. Experimental Motor Neuron Disease Induced in Mice with Long-Term Repeated Intraperitoneal Injections of Serum from ALS Patients. Int J Mol Sci 2019;20:E2573. [PMID: 31130623 DOI: 10.3390/ijms20102573] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
16 Murphy S, Zweyer M, Mundegar RR, Swandulla D, Ohlendieck K. Proteomic serum biomarkers for neuromuscular diseases. Expert Review of Proteomics 2018;15:277-91. [DOI: 10.1080/14789450.2018.1429923] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
17 Béland LC, Markovinovic A, Jakovac H, De Marchi F, Bilic E, Mazzini L, Kriz J, Munitic I. Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses. Brain Commun 2020;2:fcaa124. [PMID: 33134918 DOI: 10.1093/braincomms/fcaa124] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
18 Henkel S, Wellhausen R, Woitalla D, Marcus K, May C. Epitope Mapping Using Peptide Microarray in Autoantibody Profiling. Methods Mol Biol 2016;1368:209-24. [PMID: 26614078 DOI: 10.1007/978-1-4939-3136-1_15] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
19 Ayoglu B, Schwenk JM, Nilsson P. Antigen arrays for profiling autoantibody repertoires. Bioanalysis 2016;8:1105-26. [PMID: 27097564 DOI: 10.4155/bio.16.31] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
20 Patai R, Nógrádi B, Engelhardt JI, Siklós L. Calcium in the pathomechanism of amyotrophic lateral sclerosis - Taking center stage? Biochem Biophys Res Commun 2017;483:1031-9. [PMID: 27545602 DOI: 10.1016/j.bbrc.2016.08.089] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
21 Santacatterina F, Torresano L, Núñez-salgado A, Esparza-molto PB, Olive M, Gallardo E, García-arumi E, Blazquez A, González-quintana A, Martín MA, Cuezva JM. Different mitochondrial genetic defects exhibit the same protein signature of metabolism in skeletal muscle of PEO and MELAS patients: A role for oxidative stress. Free Radical Biology and Medicine 2018;126:235-48. [DOI: 10.1016/j.freeradbiomed.2018.08.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Murdock BJ, Bender DE, Segal BM, Feldman EL. The dual roles of immunity in ALS: Injury overrides protection. Neurobiology of Disease 2015;77:1-12. [DOI: 10.1016/j.nbd.2015.02.017] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
23 Syu GD, Dunn J, Zhu H. Developments and Applications of Functional Protein Microarrays. Mol Cell Proteomics 2020;19:916-27. [PMID: 32303587 DOI: 10.1074/mcp.R120.001936] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
24 Gonçalves M, Tillack L, de Carvalho M, Pinto S, Conradt HS, Costa J. Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis. Clin Chim Acta 2015;438:342-9. [PMID: 25261856 DOI: 10.1016/j.cca.2014.09.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
25 McCauley ME, Baloh RH. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol 2019;137:715-30. [PMID: 30465257 DOI: 10.1007/s00401-018-1933-9] [Cited by in Crossref: 75] [Cited by in F6Publishing: 69] [Article Influence: 18.8] [Reference Citation Analysis]
26 Riancho J, Delgado-Alvarado M, Andreu MD, Paz-Fajardo L, Arozamena S, Gil-Bea FJ, López de Munaín A. Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge. Br J Pharmacol 2021;178:1269-78. [PMID: 32497246 DOI: 10.1111/bph.15151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Joachim SC, Renner M, Reinhard J, Theiss C, May C, Lohmann S, Reinehr S, Stute G, Faissner A, Marcus K, Dick HB. Protective effects on the retina after ranibizumab treatment in an ischemia model. PLoS One 2017;12:e0182407. [PMID: 28800629 DOI: 10.1371/journal.pone.0182407] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]